Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs
摘要:
This report describes the design and synthesis of a series of CCR2 antagonists incorporating novel non-aryl/heteroaryl RHS (right hand side) motifs. Previous SAR in the area has suggested an aryl/heteroaryl substituent as a necessary structural feature for binding to the CCR2 receptor. Herein we describe the SAR with regards to potency (binding to hCCR2), dofetilide activity and metabolic stability (in vitro HLM) for this series. The resulting outcome was the identification of compounds with excellent properties for the investigation of the role of CCR2 in disease. (C) 2011 Elsevier Ltd. All rights reserved.
Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs
摘要:
This report describes the design and synthesis of a series of CCR2 antagonists incorporating novel non-aryl/heteroaryl RHS (right hand side) motifs. Previous SAR in the area has suggested an aryl/heteroaryl substituent as a necessary structural feature for binding to the CCR2 receptor. Herein we describe the SAR with regards to potency (binding to hCCR2), dofetilide activity and metabolic stability (in vitro HLM) for this series. The resulting outcome was the identification of compounds with excellent properties for the investigation of the role of CCR2 in disease. (C) 2011 Elsevier Ltd. All rights reserved.
3-aminocyclopentanecarboxamides as chemokine receptor agonists
申请人:Hughes Robert O.
公开号:US08946413B2
公开(公告)日:2015-02-03
There is provided a compound of Formula I(a) or I(b):
or a pharmaceutically acceptable salt thereof, wherein the various substitutents are defined herein.